cambria 1: camizestrant er /her2- early breast cancer
Published 7 months ago • 569 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
4:06
serena-2: camizestrant vs fulvestrant in post-menopausal women with advanced er /her- breast cancer
-
0:55
the cambria-2 clinical trial animation
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
0:51
ember-2: preoperative imlunestrant for er /her2- early stage breast cancer
-
4:05
camizestrant may be superior to fulvestrant in patients with hr-positive, her2-negative bc
-
6:55
mafalda oliveira, sabcs 2022: camizestrant vs fulvestrant for advanced er her2- breast cancer
-
1:11
current standards for her2 early stage breast cancer
-
0:52
patient eligibility in the ameera-6 trial of amcenestrant
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
1:22
her2dx risk-score in early-stage her2-positive breast cancer
-
4:39
case 1: approach to early stage, her2 breast cancer
-
1:44
precoopera: giredestrant versus anastrozole in er /her2- early breast cancer
-
4:18
case 1: early-stage her2 breast cancer
-
3:41
diagnosis of her2 /er- early breast cancer
-
2:46
rv-471: novel protac® estrogen receptor degrader, in er breast cancer
-
2:35
what does the future hold for serds in er breast cancer?
-
2:40
the cambria-2 clinical trial